iShares Nasdaq Biotechnology (IBB) Sees Green-to-Red Reversal
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Tweet
Share
E-mailiShares Nasdaq Biotechnology (NASDAQ: IBB) is coming in sharply from earlier highs and have turned red. IBB is down 0.3% currently.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle sets $225B revenue target for fiscal year 2030
- Fed's Warsh: did not hear any reference to politics or elections in FOMC deliberations
- DoorDash deal to buy Instacart to be announced as early as Thursday - CNBC
Create E-mail Alert Related Categories
ETFs, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
